Adjuvance Technologies Teams with Oragenics to Develop 2nd-Generation COVID Vaccine Lincoln-based biotechnology company Adjuvance Technologies (www.adjuvancetechnologies.com) has entered a partnership with Oragenics Inc. to begin
Adjuvance Technologies Celebrates $20M Investment and New Office Adjuvance Technologies (www.adjuvancetechnologies.com) recently received a $20 million Series A investment from Morningside Venture Investments Limited. The
